Trademark: 90366020
Word
CO-EVOLVED MEDICINES
Status Date
Thursday, January 4, 2024
Filing Date
Tuesday, December 8, 2020
Published for Opposition
Tuesday, November 16, 2021
5 Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
Jan 6, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2024
Sou Extension 4 Granted
Jan 4, 2024
Sou Extension 4 Filed
Jan 4, 2024
Sou Teas Extension Received
Jul 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 6, 2023
Sou Extension 3 Granted
Jul 6, 2023
Sou Extension 3 Filed
Jul 6, 2023
Sou Teas Extension Received
Jan 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2023
Sou Extension 2 Granted
Jan 3, 2023
Sou Extension 2 Filed
Jan 3, 2023
Sou Teas Extension Received
Jul 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 7, 2022
Sou Extension 1 Granted
Jul 7, 2022
Sou Extension 1 Filed
Jul 7, 2022
Sou Teas Extension Received
Jan 11, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 16, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 16, 2021
Published For Opposition
Oct 27, 2021
Notification Of Notice Of Publication E-Mailed
Oct 7, 2021
Approved For Pub - Principal Register
Oct 7, 2021
Teas/Email Correspondence Entered
Oct 7, 2021
Correspondence Received In Law Office
Oct 7, 2021
Teas Response To Office Action Received
Jun 2, 2021
Notification Of Non-Final Action E-Mailed
Jun 2, 2021
Non-Final Action E-Mailed
Jun 2, 2021
Non-Final Action Written
May 27, 2021
Assigned To Examiner
Feb 12, 2021
New Application Office Supplied Data Entered
Dec 11, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
